Dimensional Fund Advisors LP Xeris Biopharma Holdings, Inc. Transaction History

Dimensional Fund Advisors LP

  • $403 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
SELL
$1.7 - $2.45 $10,942 - $15,770
-6,437 Reduced 11.68%
48,663 $109,000
Q1 2024

May 10, 2024
BUY
$2.04 - $3.22 $112,404 - $177,422
55,100 New
55,100 $121,000
Q2 2022

Aug 12, 2022
BUY
$1.48 - $2.64 $8,418 - $15,016
5,688 Added 14.44%
45,082 $69,000
Q1 2022

May 13, 2022
SELL
$2.0 - $2.87 $60,956 - $87,471
-30,478 Reduced 43.62%
39,394 $101,000
Q4 2021

Feb 09, 2022
BUY
$1.8 - $2.93 $125,769 - $204,724
69,872 New
69,872 $204,000

Others Institutions Holding XERS

# of Institutions
143
Shares Held
60M
Call Options Held
148K
Put Options Held
45.7K
View Full List

About Xeris Biopharma Holdings, Inc.

XERS Quotes by TradingView
  • Ticker XERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,956,992
  • Market Cap $462M
  • Description
  • Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...
More about XERS
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email